These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17334909)

  • 41. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.
    Wang Y; Zhao R; Goldman ID
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6256-64. PubMed ID: 15448015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of impact of the loss of constitutive folate receptor alpha expression, achieved by RNA Interference, on the activity of the new generation antifolate pemetrexed in HeLa cells.
    Chattopadhyay S; Wang Y; Zhao R; Goldman ID
    Clin Cancer Res; 2004 Dec; 10(23):7986-93. PubMed ID: 15585634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional loss of the reduced folate carrier enhances the antitumor activities of novel antifolates with selective uptake by the proton-coupled folate transporter.
    Desmoulin SK; Wang L; Polin L; White K; Kushner J; Stout M; Hou Z; Cherian C; Gangjee A; Matherly LH
    Mol Pharmacol; 2012 Oct; 82(4):591-600. PubMed ID: 22740639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of the loss of capacity for N-glycosylation on the transport activity and cellular localization of the human reduced folate carrier.
    Wong SC; Zhang L; Proefke SA; Matherly LH
    Biochim Biophys Acta; 1998 Oct; 1375(1-2):6-12. PubMed ID: 9767079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced folate carrier: biochemistry and molecular biology of the normal and methotrexate-resistant cell.
    Bosson G
    Br J Biomed Sci; 2003; 60(2):117-29. PubMed ID: 12866924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural basis for recognition and transport of folic acid in mammalian cells.
    Newstead S
    Curr Opin Struct Biol; 2022 Jun; 74():102353. PubMed ID: 35303537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of Reduced Folate Carrier (RFC) by Vitamin D Receptor at the Blood-Brain Barrier.
    Alam C; Hoque MT; Finnell RH; Goldman ID; Bendayan R
    Mol Pharm; 2017 Nov; 14(11):3848-3858. PubMed ID: 28885847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substrate-specific binding and conformational changes involving Ser313 and transmembrane domain 8 of the human reduced folate carrier, as determined by site-directed mutagenesis and protein cross-linking.
    Hou Z; Wu J; Ye J; Cherian C; Matherly LH
    Biochem J; 2010 Sep; 430(2):265-74. PubMed ID: 20557288
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells.
    Corona G; Giannini F; Fabris M; Toffoli G; Boiocchi M
    Int J Cancer; 1998 Jan; 75(1):125-33. PubMed ID: 9426700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The reduced folate carrier (RFC) is cytotoxic to cells under conditions of severe folate deprivation. RFC as a double edged sword in folate homeostasis.
    Ifergan I; Jansen G; Assaraf YG
    J Biol Chem; 2008 Jul; 283(30):20687-95. PubMed ID: 18499665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restoration of high-level transport activity by human reduced folate carrier/ThTr1 thiamine transporter chimaeras: role of the transmembrane domain 6/7 linker region in reduced folate carrier function.
    Liu XY; Witt TL; Matherly LH
    Biochem J; 2003 Jan; 369(Pt 1):31-7. PubMed ID: 12227830
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer.
    Raz S; Stark M; Assaraf YG
    Drug Resist Updat; 2016 Sep; 28():43-64. PubMed ID: 27620954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of reduced folate carrier function and folate depletion result in enhanced pemetrexed inhibition of purine synthesis.
    Zhao R; Zhang S; Hanscom M; Chattopadhyay S; Goldman ID
    Clin Cancer Res; 2005 Feb; 11(3):1294-301. PubMed ID: 15709201
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of deletions and translocation of the reduced folate carrier gene with profound loss of gene expression in methotrexate-resistant K562 human erythroleukemia cells.
    Ding BC; Witt TL; Hukku B; Heng H; Zhang L; Matherly LH
    Biochem Pharmacol; 2001 Mar; 61(6):665-75. PubMed ID: 11266651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates.
    Backus HH; Pinedo HM; Wouters D; Padrón JM; Molders N; van Der Wilt CL; van Groeningen CJ; Jansen G; Peters GJ
    Int J Cancer; 2000 Sep; 87(6):771-8. PubMed ID: 10956384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromosomal localization of the murine RFC-1 gene encoding a folate transporter and its amplification in an antifolate resistant variant overproducing the transporter.
    Roy K; Chiao JH; Spengler BA; Tolner B; Yang CH; Biedler JL; Sirotnak FM
    Cancer Genet Cytogenet; 1998 Aug; 105(1):29-38. PubMed ID: 9689927
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The molecular identity and characterization of a Proton-coupled Folate Transporter--PCFT; biological ramifications and impact on the activity of pemetrexed.
    Zhao R; Goldman ID
    Cancer Metastasis Rev; 2007 Mar; 26(1):129-39. PubMed ID: 17340171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Contrasting effects of oncogene expression on two carrier-mediated systems internalizing folate compounds in Fisher rat 3T3 cells.
    Kühnel JM; Chiao JH; Sirotnak FM
    J Cell Physiol; 2000 Sep; 184(3):364-72. PubMed ID: 10911368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of dynein light chain road block-1 as a novel interaction partner with the human reduced folate carrier.
    Ashokkumar B; Nabokina SM; Ma TY; Said HM
    Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G480-7. PubMed ID: 19571232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Augmentation of reduced folate carrier-mediated folate/antifolate transport through an antiport mechanism with 5-aminoimidazole-4-carboxamide riboside monophosphate.
    Visentin M; Zhao R; Goldman ID
    Mol Pharmacol; 2012 Aug; 82(2):209-16. PubMed ID: 22554803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.